<DOC>
	<DOCNO>NCT01436734</DOCNO>
	<brief_summary>The aim study investigate role Trasylol glucagon prevention degradation use radioimmunoactive method I125 . Additionally different incubation time introduce human plasma sample oral glucose stimulation , also fast hypoglycemia blood sample patient ' type 2 diabetes . Since , structure technique glucagon measurement well describe nowadays .</brief_summary>
	<brief_title>Role Aprotinin Glucagon Degradation , Measurement Radioimmunoactive Method ( RIA ) I125</brief_title>
	<detailed_description />
	<criteria>Caucasians 18 year old Type 2 diabetes ( WHO criteria ) HbA1c &gt; 9 % Liver disease ( ALAT/ASAT &gt; 2 x upper normal limit ) Diabetic nephropathy ( screatinine &gt; 130 ÂµM albuminuria ) Proliferative diabetic retinopathy ( anamnestic ) Severe arteriosclerosis heart failure ( NYHA group III og IV ) Anemia treatment medication applicable pause 12 hour pregnancy lactation Fasting plasma glucose &gt; 15 mM screen day .</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>July 2015</verification_date>
</DOC>